首站-论文投稿智能助手
典型文献
Continued antigenic variation of highly pathogenic avian influenza A(H7N9)virus in laying hens in China,2020-2021
文献摘要:
Dear Editor, Since it first appeared in humans in China in 2013,a novel H7N9 influenza virus has caused 1,568 cases of infection,with a mortality rate of 39.2%(Yin et al.,2021).The early H7N9 virus strains had low path-ogenicity and did not cause avian disease(Zhang et al.,2013).However,they caused concern about poultry consumption and caused huge eco-nomic losses to the poultry industry.Since mid-2016,some H7N9 viruses mutated,with an insertion of four basic amino acids in their cleavage sites of hemagglutinin(HA)and thereby became highly pathogenic to chickens,causing multiple outbreaks in poultry in China(Wang et al.,2017;Hou et al.,2019).
文献关键词:
作者姓名:
Wenming Jiang;Xin Yin;Shuo Liu;Shaobo Liang;Cheng Peng;Guangyu Hou;Jinping Li;Xiaohui Yu;Yang Li;Jingjing Wang;Hualei Liu
作者机构:
China Animal Health and Epidemiology Center,Qingdao,266032,China
文献出处:
引用格式:
[1]Wenming Jiang;Xin Yin;Shuo Liu;Shaobo Liang;Cheng Peng;Guangyu Hou;Jinping Li;Xiaohui Yu;Yang Li;Jingjing Wang;Hualei Liu-.Continued antigenic variation of highly pathogenic avian influenza A(H7N9)virus in laying hens in China,2020-2021)[J].中国病毒学,2022(04):631-633
A类:
ogenicity
B类:
Continued,antigenic,variation,highly,pathogenic,avian,influenza,H7N9,laying,hens,China,Dear,Editor, Since,first,appeared,humans,novel,has,caused,cases,infection,mortality,rate,Yin,et,early,strains,had,low,did,not,disease,Zhang,However,they,concern,about,poultry,consumption,huge,eco,nomic,losses,industry,mid,some,viruses,mutated,insertion,four,basic,amino,acids,their,cleavage,sites,hemagglutinin,HA,thereby,became,chickens,causing,multiple,outbreaks,Wang,Hou
AB值:
0.651489
相似文献
Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis
Jinghui Lei;Xiaoyu Jiang;Wei Li;Jie Ren;Datao Wang;Zhejun Ji;Zeming Wu;Fang Cheng;Yusheng Cai;Zheng-Rong Yu;Juan Carlos Izpisua Belmonte;Chunyi Li;Guang-Hui Liu;Weiqi Zhang;Jing Qu;Si Wang-Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Institute of Antler Science and Product Technology,Changchun Sci-Tech University,Changchun 130000,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;National Laboratory of Biomacromolecules,CAS Center for Excellence in Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;Department of Orthopaedics,Peking University First Hospital,Beijing 100034,China;Gene Expression Laboratory,Salk Institute for Biological Studies,La Jolla,CA,USA
Low-dose chloroquine treatment extends the lifespan of aged rats
Wei Li;Zhiran Zou;Yusheng Cai;Kuan Yang;Si Wang;Zunpeng Liu;Lingling Geng;Qun Chu;Zhejun Ji;Piu Chan;Guang-Hui Liu;Moshi Song;Jing Qu;Weiqi Zhang-Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China;Sino-Danish Center for Education and Research,Beijing 101408,China;Chongqing Renji Hospital,University of Chinese Academy of Sciences,Chongqing 400062,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China
Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
Hezhen Shan;Lingling Geng;Xiaoyu Jiang;Moshi Song;Jianxun Wang;Zunpeng Liu;Xiao Zhuo;Zeming Wu;Jianli Hu;Zhejun Ji;Si Wang;Piu Chan;Jing Qu;Weiqi Zhang;Guang-Hui Liu-State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;School of Life Sciences,Beijing University of Chinese Medicine,Beijing 100029,China;Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;University of Chinese Academy of Sciences,Beijing 100049,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China
FTO stabilizes MIS12 and counteracts senescence
Sheng Zhang;Zeming Wu;Yue Shi;Si Wang;Jie Ren;Zihui Yu;Daoyuan Huang;Kaowen Yan;Yifang He;Xiaoqian Liu;Qianzhao Ji;Beibei Liu;Zunpeng Liu;Jing Qu;Guang-Hui Liu;Weimin Ci;Xiaoqun Wang;Weiqi Zhang-State Key Laboratory of Brain and Cognitive Science,CAS Center for Excellence in Brain Science and Intelligence Technology,Institute of Brain-Intelligence Technology(Shanghai),Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Advanced Innovation Center for Human Brain Protection,and National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,International Center for Aging and Cancer,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Chongqing Renji Hospital,University of Chinese Academy of Sciences,Chongqing 400062,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Brain Disorders,Beijing 100069,China
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
Li Jingxin;Zhang Li;Bao Linlin;Wang Yuxiao;Qiu Lin;Hu Jialei;Tang Rong;Yu Huiyan;Shan Jun;Li Yan;Qin Chuan;Zhu Fengcai-Department for Vaccine Clinical Evaluation, NHC Key Laboratory of Enteric Pathogenic Microbiology, Jlangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu 210009, China;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC); Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, Beijing 100101, China;Department of Public Health, Southeast University, Nanjing, Jiangsu 210009, China;Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma;Xinghai Zhang;Peiyi Zheng;Peter H.Dube;Weihong Zeng;Shaohong Chen;Qingyu Cheng;Yunru Yang;Yan Wu;Junhui Zhou;Xiaowen Hu;Yan Xiang;Huajun Zhang;Sandra Chiu;Tengchuan Jin-Department of Pulmonary and Critical Care Medicine,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;Laboratory of Structural Immunology,CAS Key Laboratory of Innate Immunity and Chronic Disease,Hefei National Laboratory for Physical Sciences at Microscale,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;Department of Microbiology,Immunology and Molecular Genetics,University of Texas Health Science Center at San Antonio,San Antonio,TX,USA;University of Chinese Academy of Sciences,Beijing,China;Institute of Health and Medicine,Hefei Comprehensive National Science Center,Hefei,Anhui,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。